DiamiR

DiamiR is a private molecular diagnostics company that focuses on developing minimally invasive tests for the detection and monitoring of pathology, based on the quantitative analysis of organ-enriched microRNA signatures in plasma, used for screening, patient stratification, as well as disease progression and treatment monitoring. DiamiR collaborates with leading academic centers, disease foundations, and biopharmaceutical companies.